1. Sun, Haoran, Zhang, Jun, Ye, Qianqian, Su, Chuan, Shi, Yuguang. 2023. LPGAT1 controls MEGDEL syndrome by coupling phosphatidylglycerol remodeling with mitochondrial transport. In Cell reports, 42, 113214. doi:10.1016/j.celrep.2023.113214. https://pubmed.ncbi.nlm.nih.gov/37917582/
2. Gong, Huiyuan, Ma, Chao, Li, Xiaojun, Wu, Nan, Wang, Xiaojing. . Upregulation of LPGAT1 Enhances Lung Adenocarcinoma Proliferation. In Frontiers in bioscience (Landmark edition), 28, 89. doi:10.31083/j.fbl2805089. https://pubmed.ncbi.nlm.nih.gov/37258473/
3. Traurig, Michael T, Orczewska, Julieanna I, Ortiz, Daniel J, Bogardus, Clifton, Baier, Leslie J. . Evidence for a role of LPGAT1 in influencing BMI and percent body fat in Native Americans. In Obesity (Silver Spring, Md.), 21, 193-202. doi:10.1002/oby.20243. https://pubmed.ncbi.nlm.nih.gov/23505186/
4. Zhang, Xiaoyang, Zhang, Jun, Sun, Haoran, Nie, Jia, Shi, Yuguang. 2019. Defective Phosphatidylglycerol Remodeling Causes Hepatopathy, Linking Mitochondrial Dysfunction to Hepatosteatosis. In Cellular and molecular gastroenterology and hepatology, 7, 763-781. doi:10.1016/j.jcmgh.2019.02.002. https://pubmed.ncbi.nlm.nih.gov/30831319/
5. Fang, Tao, Shen, Na, Shi, Zhemin, Wang, Jing, Hou, Shike. 2024. Biological mechanism and functional verification of key genes related to major depressive disorder and type 2 diabetes mellitus. In Mammalian genome : official journal of the International Mammalian Genome Society, 36, 66-82. doi:10.1007/s00335-024-10090-z. https://pubmed.ncbi.nlm.nih.gov/39656235/